Profile data is unavailable for this security.
About the company
BellRing Brands, Inc., formerly BellRing Distribution LLC, is a consumer product holding company. The Company is a provider of ready-to-drink (RTD) protein shakes, other RTD beverages, powders, nutrition bars and nutritional supplements. It operates through protein-based consumer goods. The Company’s primary brands are Premier Protein and Dymatize. Premier Protein’s product portfolio consists of RTD protein shakes, refreshing protein beverages, nutrition bars and protein powders. Dymatize brand’s portfolio includes an assortment of sports nutrition products, including primarily protein powders as well as nutritional supplements. Its products are distributed across a diverse network of channels, including club, food, drug and mass (FDM), e-commerce, specialty and convenience.
- Revenue in USD (TTM)1.84bn
- Net income in USD191.50m
- Incorporated2021
- Employees420.00
- LocationBellring Brands Inc2503 S. Hanley RoadST. LOUIS 63144United StatesUSA
- Phone+1 (314) 644-6400
- Fax+1 (302) 636-5454
- Websitehttps://bellring.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Exelixis Inc | 1.85bn | 205.05m | 6.09bn | 1.31k | 32.34 | 2.90 | 26.45 | 3.30 | 0.6466 | 0.6466 | 5.84 | 7.21 | 0.621 | 3.12 | 7.78 | 1,409,653.00 | 6.90 | 8.86 | 7.82 | 9.91 | 95.70 | 96.30 | 11.10 | 15.43 | 3.41 | -- | 0.00 | 0.00 | 13.60 | 16.47 | 13.98 | -21.34 | 3.98 | -- |
| Cytokinetics, Inc. | 3.75m | -530.60m | 6.24bn | 423.00 | -- | -- | -- | 1,663.63 | -5.40 | -5.40 | 0.0382 | -3.78 | 0.0044 | -- | 4.08 | 8,869.98 | -62.50 | -43.14 | -69.19 | -47.22 | -- | -- | -14,141.74 | -540.47 | -- | -15.26 | 2.78 | -- | -92.04 | -24.89 | -35.30 | -- | 9.76 | -- |
| Revolution Medicines Inc | 4.57m | -484.27m | 6.50bn | 411.00 | -- | 3.77 | -- | 1,424.03 | -3.76 | -3.76 | 0.035 | 10.46 | 0.0031 | -- | 2.29 | 12,079.37 | -32.48 | -29.76 | -34.18 | -32.59 | -- | -- | -10,606.04 | -606.93 | -- | -- | 0.00 | -- | -67.27 | -10.50 | -75.46 | -- | 38.82 | -- |
| Blueprint Medicines Corp | 282.21m | -288.29m | 6.57bn | 645.00 | -- | 21.15 | -- | 23.29 | -4.82 | -4.82 | 4.59 | 4.96 | 0.2499 | 0.3531 | 6.18 | 430,853.40 | -25.53 | -29.92 | -30.68 | -34.06 | 96.97 | -- | -102.15 | -116.65 | 3.61 | -23.37 | 0.4352 | -- | 22.22 | 41.14 | 9.06 | -- | 4.85 | -- |
| Intra-Cellular Therapies Inc | 513.93m | -110.87m | 6.86bn | 610.00 | -- | 10.57 | -- | 13.35 | -1.15 | -1.15 | 5.34 | 6.15 | 0.6996 | 1.67 | 4.83 | 842,508.20 | -15.09 | -38.27 | -17.67 | -42.77 | 92.82 | -- | -21.57 | -128.42 | 5.00 | -- | 0.00 | -- | 85.51 | -- | 45.49 | -- | -7.22 | -- |
| Jazz Pharmaceuticals PLC | 3.84bn | 330.79m | 6.87bn | 2.80k | 22.49 | 1.86 | 7.02 | 1.79 | 4.85 | 4.85 | 55.49 | 58.65 | 0.3436 | 0.6428 | 5.78 | 1,372,634.00 | 2.99 | 1.48 | 3.36 | 1.62 | 89.53 | 88.79 | 8.69 | 4.26 | 1.90 | 1.87 | 0.607 | 0.00 | 4.78 | 15.19 | 285.14 | -1.49 | -20.04 | -- |
| Viking Therapeutics Inc | 0.00 | -93.72m | 7.39bn | 28.00 | -- | 7.91 | -- | -- | -0.9305 | -0.9305 | 0.00 | 8.47 | 0.00 | -- | -- | 0.00 | -16.76 | -21.91 | -17.52 | -23.04 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -24.73 | -- | -- | -- |
| Bellring Brands Inc | 1.84bn | 191.50m | 7.49bn | 420.00 | 39.92 | -- | 31.66 | 4.06 | 1.44 | 1.44 | 13.84 | -1.90 | 2.40 | 5.40 | 8.71 | 4,389,286.00 | 24.91 | 18.89 | 31.72 | -- | 32.74 | 32.44 | 10.39 | 10.10 | 1.84 | 5.07 | 1.42 | 0.00 | 21.53 | 15.03 | 101.09 | 13.80 | -18.48 | -- |
| Cerevel Therapeutics Holdings Inc | 0.00 | -460.47m | 7.67bn | 355.00 | -- | 13.57 | -- | -- | -2.72 | -2.72 | 0.00 | 3.10 | 0.00 | -- | -- | 0.00 | -44.76 | -- | -48.20 | -- | -- | -- | -- | -- | -- | -- | 0.3745 | -- | -- | -- | -23.14 | -- | -- | -- |
| Vaxcyte Inc | 0.00 | -436.82m | 8.11bn | 254.00 | -- | 4.09 | -- | -- | -4.22 | -4.22 | 0.00 | 18.24 | 0.00 | -- | -- | 0.00 | -28.19 | -34.22 | -29.52 | -37.21 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -80.00 | -- | 107.28 | -- |
| Legend Biotech Corp (ADR) | 342.80m | -465.95m | 8.22bn | 1.80k | -- | 7.07 | -- | 23.96 | -2.60 | -2.60 | 1.90 | 6.39 | 0.2297 | 9.52 | 203.86 | 190,443.30 | -31.22 | -37.71 | -37.33 | -47.19 | 52.35 | -- | -135.92 | -286.51 | 5.57 | -24.44 | 0.2233 | -- | 143.70 | 42.15 | -16.11 | -- | 1.57 | -- |
| Elanco Animal Health Inc | 4.37bn | -1.30bn | 8.49bn | 9.30k | -- | 1.40 | -- | 1.95 | -2.64 | -2.64 | 8.84 | 12.26 | 0.2931 | 1.21 | 4.28 | 469,354.80 | -8.74 | -3.27 | -9.65 | -3.65 | 55.28 | 54.28 | -29.83 | -11.53 | 1.96 | 0.853 | 0.4877 | -- | 0.136 | 7.57 | -1,478.21 | -- | 2.74 | -- |
| KBR Inc | 7.07bn | -258.00m | 8.81bn | 34.00k | -- | 6.28 | -- | 1.25 | -1.91 | -1.91 | 52.67 | 10.46 | 1.25 | -- | 5.56 | 207,970.60 | -4.45 | 0.4725 | -6.46 | 0.6678 | 13.86 | 12.18 | -3.58 | 0.4122 | -- | 1.17 | 0.5678 | 340.00 | 5.97 | 7.20 | -240.21 | -- | 36.31 | 11.03 |
| Roivant Sciences Ltd | 123.24m | 4.35bn | 9.05bn | 904.00 | 2.22 | 1.48 | 2.12 | 73.43 | 5.07 | 5.23 | 0.1597 | 7.57 | 0.0259 | -- | 3.57 | 136,328.50 | 89.08 | -- | 105.17 | -- | 87.57 | -- | 3,439.02 | -- | 27.77 | -- | 0.0638 | -- | 10.84 | -- | -32.93 | -- | -- | -- |
Data as of May 17 2024. Currency figures normalised to Bellring Brands Inc's reporting currency: US Dollar USD
45.15%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| BlackRock Fund Advisorsas of 31 Mar 2024 | 14.48m | 11.06% |
| The Vanguard Group, Inc.as of 31 Mar 2024 | 13.71m | 10.47% |
| Wasatch Advisors, Inc.as of 31 Mar 2024 | 5.98m | 4.57% |
| SSgA Funds Management, Inc.as of 31 Mar 2024 | 4.70m | 3.59% |
| T. Rowe Price Investment Management, Inc.as of 31 Mar 2024 | 4.68m | 3.57% |
| AllianceBernstein LPas of 31 Mar 2024 | 3.72m | 2.84% |
| Franklin Advisers, Inc.as of 31 Mar 2024 | 3.50m | 2.68% |
| Geode Capital Management LLCas of 31 Mar 2024 | 3.06m | 2.34% |
| Invesco Advisers, Inc.as of 31 Mar 2024 | 2.97m | 2.27% |
| Dimensional Fund Advisors LPas of 31 Mar 2024 | 2.34m | 1.78% |
More ▼
Data from 31 Mar 2024 - 31 Mar 2024Source: FactSet Research Systems Inc.
